Skip to main content

Pennsylvania

In Pennsylvania, individuals diagnosed with prostate cancer face a crucial decision amidst a vast landscape of treatment options. The state is home to numerous prestigious healthcare institutions, each providing a variety of approaches to combat this disease. Among these, one particular treatment stands out for its innovative approach and precision: LDR Brachytherapy. This advanced treatment option, which we are proud to collaborate on with your urologist, is distinctively available through our partnership, offering a level of care and specialization not found elsewhere in Pennsylvania.

LDR Brachytherapy targets prostate cancer with unmatched precision, minimizing the impact on surrounding healthy tissue. This is achieved by implanting tiny radioactive seeds directly into the prostate, providing a continuous, targeted dose of radiation right where it’s needed. This precision mirrors the thoughtful approach we take towards healthcare, ensuring that each patient receives a treatment as individualized as their needs.

Our collaboration with leading urologists in Pennsylvania ensures that you receive a seamless treatment experience that is both personalized and cutting-edge. Leveraging the latest in artificial intelligence, we enhance the precision of seed placement, customizing the treatment to fit the specific dimensions of your prostate cancer. This collaborative approach not only aims for the highest cure rates but also significantly reduces the likelihood of side effects and infections, delivering outcomes that surpass those of any other radiation therapy. In fact, LDR brachytherapy’s outcomes surpass that of proton therapy and stereotactic body radiation therapy.

LDR Brachytherapy can be administered as the sole treatment option for early-stage disease, offering a less invasive and highly effective alternative. For more intermediate and high-risk diseases, it can serve as a boost in conjunction with external beam radiation, providing a comprehensive approach to treatment that addresses the unique aspects of each patient’s cancer. Focal brachytherapy is an emerging option that can be used in select early-stage cases and for recurrence after external beam radiation.

Choosing the right path in a state celebrated for its medical innovation and excellence is crucial. The unique access to LDR Brachytherapy through our partnership highlights a dedicated effort to offer you a cutting-edge treatment option. Here, alongside your urologist, we prioritize your health and comfort, guiding you through a tailored treatment journey that maximizes your quality of life and is designed with your well-being in mind, embodying the spirit of independence that defines Pennsylvania.

Meet Your Physicians

Manuj Agarwal, MD

  • Med School & Residency: SUNY Downstate Medical Center
  • Fellowship trained Brachytherapist
  • Leadership roles in the American Brachytherapy Society
  • Nationally recognized Prostate Cancer Specialist with over a decade of experience
  • Co-founder of Prostate Cancer Institute of Pennsylvania
  • Prior faculty member at the University of Pennsylvania

Ajay Bhatnagar, MD, MBA

  • Founder of PCIA
  • Downingtown Senior High School Graduate
  • University of Pennsylvania Undergraduate, Magna Cum Laude
  • Med School & Residency: Univ of Pittsburgh
  • 15 years of private practice experience
  • 20 years of LDR Brachytherapy experience
  • 2023 America’s Best Doctors Award
  • 2024 Phoenix Magazine Top Doc Award

In 2024, Dr. Ajay Bhatnagar was nominated for the prestigious Phoenix Magazine Toc Doc Award.

Prostate Cancer Institute of Pennsylvania

Address
400 Davis Drive, Suite 200b
Plymouth Meeting, PA 19462

Phone
(267) 289-7247

Fax
(267) 289-7257

Hours Of Operation
Monday: 8:00 AM – 4:00 PM
Tuesday: 8:00 AM – 4:00 PM
Wednesday: 8:00 AM – 4:00 PM
Thursday: 8:00 AM – 4:00 PM
Friday: 8:00 AM – 4:00 PM
Saturday: Closed
Sunday: Closed

BOOK ONLINE(267) 289-7247

Contact Us

If you have any questions, concerns, or comments, please fill out the short contact form below.

    Skip to content